OTC Artificial Tears Market Trends 2021 | Segmentation, Outlook, Industry Report to 2027

The OTC Artificial Tears Market size is expected to grow at an annual average of 3% during 2021-2027. Artificial tears are lubricant eye drops, mainly used to treat dryness and irritation caused by insufficient tear production. These artificial tears are formulated to initiate natural tears and treat a variety of eye disorders such as allergies, infections, and protection from UV and blue light. It has also been used to moisturize contact lenses.

The following segmentation are covered in this report:

By Product

• Solution
• Ointment
• Emulsion
• Gel
• Spray Solution
• Suspensions

By Formulation

• Preservative Based
• Non-Preservative Based

By Application

• Dry Eye Syndrome
• Allergies
• Infections
• UV & Blue Light Protection
• Contact Lens Moisture Retention
• Others

Company Profile

• AbbVie, Inc.
• Akorn, Inc.
• Alcon
• Bausch and Lamb
• Johnson and Johnson
• OcuSoft
• Santen Pharmaceutical Co. Ltd
• Similasan Corporation 
• Sun Pharmaceutical Industries Limited
• Ursapharm Arzneimittel GmbH

Scope of the report

The research study analyses the OTC Artificial Tears Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by OTC Artificial Tears Market Report

• What was the OTC Artificial Tears Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the OTC Artificial Tears Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.